TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 0.100nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 0.300nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 0.550nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 0.600nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1nMAssay Description:Binding affinity to RAGE (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1.10nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1.20nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 1.40nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 2nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 3nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 3.10nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 4nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 4nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 4nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 6nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 6.5nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 8nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 9.70nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 9.80nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 12nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 12.7nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 13nMAssay Description:Binding affinity to recombinant human RAGE assessed as dissociation constantMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 15nMAssay Description:Binding affinity to RAGE (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 15nMAssay Description:Binding affinity to human RAGE domain V by autoradiographyMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 18nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 20nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 22.3nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKi: 25nMAssay Description:Inhibition of amyloid beta binding to RAGE (unknown origin) transfected in CHO cellsMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKi: 25nMAssay Description:Displacement of [I125]amyloid beta (1 to 40) from human RAGE domain V expressed in CHO cellsMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 30nMAssay Description:Binding affinity to human C-terminal His-tagged RAGE domain V (24 to 125 residues) expressed in Escherichia coli BL21(DE3) by tryptophan fluorescence...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 32nMAssay Description:Inhibition of CML binding to RAGE (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 43nMAssay Description:Binding affinity to human His-tagged RAGE domain VC1 expressed in Escherichia coli by fluorescence titration methodMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 75nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 78nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 99.8nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 123nMAssay Description:Day 1Step 1. Add 50 μl anti-mDial (1:160 dilution in 0.1M NaHCO3 pH 9.6)/well. Incubate overnight at 4° C.Day 2Step 2. Use the plate washer to a...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKi: 148nMAssay Description:Inhibition of HMGB1 binding to human RAGE domain V expressed in CHO cellsMore data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Human)
The State University of New York
US Patent
The State University of New York
US Patent
Affinity DataKd: 219nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
